德展健康
(000813)
| 流通市值：56.93亿 | | | 总市值：56.94亿 |
| 流通股本：21.65亿 | | | 总股本：21.65亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 101,250,441.65 | 498,088,171.28 | 335,143,687.81 | 220,809,774.68 |
| 营业收入 | 101,250,441.65 | 498,088,171.28 | 335,143,687.81 | 220,809,774.68 |
| 二、营业总成本 | 106,513,804.78 | 468,292,393.88 | 328,972,818.54 | 207,603,670.04 |
| 营业成本 | 49,031,282.39 | 205,535,638.92 | 136,432,990.24 | 85,738,551.57 |
| 税金及附加 | 3,082,810.83 | 11,467,467.09 | 9,071,318.04 | 5,894,489.8 |
| 销售费用 | 16,885,140.89 | 91,603,136.08 | 65,687,800.69 | 41,495,247.94 |
| 管理费用 | 43,556,468.32 | 173,559,265.33 | 126,863,595.37 | 77,846,959.67 |
| 研发费用 | 10,877,646.84 | 51,095,963.9 | 37,686,122.01 | 26,259,832.69 |
| 财务费用 | -16,919,544.49 | -64,969,077.44 | -46,769,007.81 | -29,631,411.63 |
| 其中:利息费用 | 97,332.9 | 365,894.26 | 302,921.58 | 235,054.36 |
| 其中:利息收入 | 17,047,087.43 | 68,006,940.85 | 51,141,106.34 | 34,448,059.48 |
| 加:投资收益 | -1,775,111.21 | 80,311,589.36 | 62,154,545.86 | -8,468,159.56 |
| 资产处置收益 | - | -34,109.82 | -1,068.87 | - |
| 资产减值损失(新) | -23,412.26 | -21,990,168.41 | -14,160,403.6 | -15,732,030.23 |
| 信用减值损失(新) | -10,610,955.45 | -12,570,742.93 | -9,776,037.58 | -7,563,908.66 |
| 其他收益 | 1,049,674.97 | 4,711,536.08 | 2,242,670.62 | 1,816,850.96 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -16,623,167.08 | 80,223,881.68 | 46,630,575.7 | -16,741,142.85 |
| 加:营业外收入 | 11,435.06 | 3,002,081.9 | 2,981,727.7 | 155,934.99 |
| 减:营业外支出 | 873,648.47 | 1,385,170.22 | 1,159,408.77 | 639,187.37 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -17,485,380.49 | 81,840,793.36 | 48,452,894.63 | -17,224,395.23 |
| 减:所得税费用 | 4,128,511.06 | 27,599,099.84 | 10,035,549.59 | 9,099,292.55 |
| 六、净利润 | -21,613,891.55 | 54,241,693.52 | 38,417,345.04 | -26,323,687.78 |
| 持续经营净利润 | -21,613,891.55 | 54,241,693.52 | 38,417,345.04 | -26,323,687.78 |
| 归属于母公司股东的净利润 | -16,805,072.84 | 83,314,246.81 | 61,365,294.29 | -7,564,371.15 |
| 少数股东损益 | -4,808,818.71 | -29,072,553.29 | -22,947,949.25 | -18,759,316.63 |
| (一)基本每股收益 | -0.01 | 0.04 | 0.03 | 0 |
| (二)稀释每股收益 | -0.01 | 0.04 | 0.03 | 0 |
| 八、其他综合收益 | - | -2,125,000 | - | - |
| 归属于母公司股东的其他综合收益 | - | -2,125,000 | - | - |
| 九、综合收益总额 | -21,613,891.55 | 52,116,693.52 | 38,417,345.04 | -26,323,687.78 |
| 归属于母公司股东的综合收益总额 | -16,805,072.84 | 81,189,246.81 | 61,365,294.29 | -7,564,371.15 |
| 归属于少数股东的综合收益总额 | -4,808,818.71 | -29,072,553.29 | -22,947,949.25 | -18,759,316.63 |
| 公告日期 | 2024-04-25 | 2024-04-12 | 2023-10-26 | 2023-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |